Treatment of Hyperhidrosis With Oxybutynin

Treatment of Hyperhidrosis With Oxybutynin: a Randomized Controlled Double Blind Against Placebo

Evaluation of the effectiveness of oxybutynin in hyperhidrosis

Inclusion Criteria:

• Age greater than 18 years
• Patient affiliated to social security or beneficiary of such a regime
• Patient able to consent
• Patient with hyperhidrosis, generalized or localized (palmar, plantar, axillary) and whose score HDSS (Hyperidrosis Disease Severity Scale) is greater than two.

Exclusion Criteria:

• Age less than 18 years
• Patient who can't be followed
• Patient participating in another clinical trial
• Pregnant
• Woman breastfeeding
• Hypersensitivity to oxybutynin or any of the excipients
• Risk of urinary retention related disorders uretroprostatiques
• Intestinal obstruction
• Toxic megacolon
• Intestinal atony
• Severe Ulcerative Colitis
• Myasthenia
• Closure glaucoma the anterior chamber angle or slightly deep